HIV molecular immunology database


Search CTL/CD8+ T-Cell Epitope Database

Found 1 matching record:

Displaying record number 53806

Download this epitope record as JSON.

HXB2 Location gp160(89-97)
gp160 Epitope Map
Author Location gp160
Epitope VTEEFNMWK Epitope Alignment
VTEEFNMWK epitope logo
Show epitope variants
Subtype A, B, C, D
Species (MHC/HLA) human
Immunogen HIV-1 infection, vaccine
Patient MHC/HLA A*32:01, A*36:01, B*53:01, B*81:01, C*04:01, C*08:04; A*24:02, A*32:01, B*51:01, B*53:01, C*04:01, C*06:02
Country Kenya
Experimental methods CD8 T-cell Elispot - IFNγ, Other
Keywords subtype comparisons, variant cross-reactivity

Vaccine Details

Vaccine type vaccinia
Vaccine strain A clade, B clade, D clade NDK, C clade consensus
Vaccine component Env



McKinnon2005 Lyle R. McKinnon, T. Blake Ball, Joshua Kimani, Charles Wachihi, Lucy Matu, Ma Luo, Joanne Embree, Keith R. Fowke, and Francis A. Plummer. Cross-Clade CD8+ T-Cell Responses With a Preference for the Predominant Circulating Clade. J. Acquir. Immune Defic. Syndr., 40(3):245-249, 1 Nov 2005. PubMed ID: 16249696. Show all entries for this paper.

Questions or comments? Contact us at
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health